AEM vs CMCL

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

CMCL presents a compelling value opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price ($25.26) that sits below both its Graham Number ($29.30) and its growth-based Intrinsic Value ($83.48). The company exhibits exceptional profitability with an ROE of 26.07% and a very conservative debt-to-equity ratio of 0.11. While the technical trend is currently bearish (0/100) and recent earnings beats are sparse, the explosive year-over-year earnings growth of 122.7% and a low forward P/E of 4.87 suggest significant undervaluation.